Risk Factors Associated with Invasive Pulmonary Mycosis Among Severe Influenza Patients in Beijing City, China

References

• WHO. Influenza (Seasonal) Fact Sheet; 2016.
   Google Scholar
• Akers IE, Weber R, Sax H, Böni J, Trkola A, Kuster SP. Influence of time to diagnosis of severe influenza on antibiotic use, length of stay, isolation precautions, and mortality: a retrospective study. Influenza Other Respir Viruses. 2017;11(4):337–344. doi:10.1111/irv.12454
   PubMed Web of Science ®Google Scholar
• Beumer MC, Koch RM, van Beuningen D, et al. Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Crit Care. 2019;50:59–65. doi:10.1016/j.jcrc.2018.11.013
   PubMed Web of Science ®Google Scholar
• Kash JC, Taubenberger JK. The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol. 2015;185(6):1528–1536. doi:10.1016/j.ajpath.2014.08.030
   PubMed Web of Science ®Google Scholar
• Grimaldi D, Llitjos JF, Pène F. Post-infectious immune suppression: a new paradigm of severe infections. Med Mal Infect. 2014;44(10):455–463. doi:10.1016/j.medmal.2014.07.017
   PubMed Web of Science ®Google Scholar
• Shi SJ, Li H, Liu M, et al. Mortality prediction to hospitalized patients with influenza pneumonia: PO2 /FiO2 combined lymphocyte count is the answer. Clin Respir J. 2017;11(3):352–360. doi:10.1111/crj.12346
   PubMed Web of Science ®Google Scholar
• Abbott JD, Fernando HV, Gurling K, Meade BW. Pulmonary aspergillosis following post-influenzal bronchopneumonia treated with antibiotics. Br Med J. 1952;1(4757):523–525. doi:10.1136/bmj.1.4757.523
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis. 2016;3(3):ofw171. doi:10.1093/ofid/ofw171
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang N, Huang X, et al. Invasive pulmonary aspergillosis in patients with influenza infection: a retrospective study and review of the literature. Clin Respir J. 2019;13(4):202–211. doi:10.1111/crj.12995
   PubMed Web of Science ®Google Scholar
• Guervilly C, Roch A, Ranque S, et al. A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia. J Infect. 2012;65(5):470–473. doi:10.1016/j.jinf.2012.07.007
   PubMed Web of Science ®Google Scholar
• Waldeck F, Boroli F, Suh N, et al. Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis. 2020;39(10):1915–1923. doi:10.1007/s10096-020-03923-7
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• De Pascale G, Tumbarello M. Fungal infections in the ICU: advances in treatment and diagnosis. Curr Opin Crit Care. 2015;21(5):421–429. doi:10.1097/MCC.0000000000000230
   PubMed Web of Science ®Google Scholar
• Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis. 2006;6:303–312. doi:10.1016/S1473-3099(06)70466-2
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH, Kraft CS. Diagnosing invasive candidiasis. J Clin Microbiol. 2018;56(5):e01909–e01917. doi:10.1128/JCM.01909-17
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Kett DH, Wauters J. Defining standards of CARE for invasive fungal diseases in the ICU. J Antimicrob Chemother. 2019;74(Suppl2):ii9–ii15. doi:10.1093/jac/dkz038
   PubMed Web of Science ®Google Scholar
• Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309:275–282. doi:10.1001/jama.2012.194139
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58(38):1071–1074.
   PubMedGoogle Scholar
• Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010;134(2):235–243. doi:10.5858/134.2.235
   PubMed Web of Science ®Google Scholar
• Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181(1):72–79. doi:10.1164/rccm.200909-1420OC
   PubMed Web of Science ®Google Scholar
• Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012;38(11):1761–1768. doi:10.1007/s00134-012-2673-2
   PubMed Web of Science ®Google Scholar
• Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2018;31(6):471–480. doi:10.1097/QCO.0000000000000504
   PubMed Web of Science ®Google Scholar
• Fischer JJ, Walker DH. Invasive pulmonary aspergillosis associated with influenza. JAMA. 1979;241(14):1493–1494. doi:10.1001/jama.1979.03290400053024
   PubMed Web of Science ®Google Scholar
• Horn CR, Wood NC, Hughes JA. Invasive aspergillosis following post-influenzal pneumonia. Br J Dis Chest. 1983;77(4):407–410. doi:10.1016/0007-0971(83)90078-5
   PubMedGoogle Scholar
• Alshabani K, Haq A, Miyakawa R, Palla M, Soubani AO. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Rev Respir Med. 2015;9(1):89–96. doi:10.1586/17476348.2015.996132
   PubMed Web of Science ®Google Scholar
• Althoff Souza C, Müller NL, Marchiori E, Escuissato DL, Franquet T. Pulmonary invasive aspergillosis and candidiasis in immunocompromised patients: a comparative study of the high-resolution CT findings. J Thorac Imaging. 2006;21(3):184–189. doi:10.1097/01.rti.0000213552.16011.ad
   PubMed Web of Science ®Google Scholar
• Chen KY, Ko SC, Hsueh PR, Luh KT, Yang PC. Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest. 2001;120(1):177–184. doi:10.1378/chest.120.1.177
   PubMed Web of Science ®Google Scholar
• Pound MW, Drew RH, Perfect JR. Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia. Curr Opin Infect Dis. 2002;15(2):183–194. doi:10.1097/00001432-200204000-00014
   PubMed Web of Science ®Google Scholar
• Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270–277. doi:10.1136/thoraxjnl-2014-206291
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe A, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792. doi:10.1016/S2213-2600(18)30274-1
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Barba P, Arnan M, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis. 2011;53(6):e16–e19. doi:10.1093/cid/cir485
   PubMed Web of Science ®Google Scholar
• Adalja AA, Sappington PL, Harris SP, et al. Isolation of aspergillus in three 2009 H1N1 influenza patients. Influenza Other Respir Viruses. 2011;5(4):225–229. doi:10.1111/j.1750-2659.2011.00202.x
   PubMed Web of Science ®Google Scholar
• Veerdonk F, Dewi I, Cunha C, et al. Inhibition of host neuraminidase increases susceptibility to invasive pulmonary aspergillosis. Open Forum Infect Dis. 2018;5(suppl 1):S36. doi:10.1093/ofid/ofy209.083
   Google Scholar
• Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial [published correction appears in Lancet. Lancet. 2009;374(9698):1351–1363.
   PubMed Web of Science ®Google Scholar